Literature DB >> 7047267

Sulphadoxine-pyrimethamine therapy in Crohn's disease.

P R Elliott, W R Burnham, L M Berghouse, J E Lennard-Jones, M J Langman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7047267     DOI： 10.1159/000198703

Source DB:  PubMed          Journal:  Digestion        ISSN： 0012-2823            Impact factor:   3.216


× No keyword cloud information.
  5 in total

1.  European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Authors:  S P L Travis; E F Stange; M Lémann; T Oresland; Y Chowers; A Forbes; G D'Haens; G Kitis; A Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J Mortensen
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

2.  Controlled trial of rifampicin and ethambutol in Crohn's disease.

Authors:  J L Shaffer; S Hughes; B D Linaker; R D Baker; L A Turnberg
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

Review 3.  Anti-tuberculous therapy for maintenance of remission in Crohn's disease.

Authors:  Petrease H Patton; Claire E Parker; John K MacDonald; Nilesh Chande
Journal:  Cochrane Database Syst Rev       Date:  2016-07-22

4.  Controlled trial of antituberculous chemotherapy in Crohn's disease: a five year follow up study.

Authors:  G A Thomas; G L Swift; J T Green; R G Newcombe; C Braniff-Mathews; J Rhodes; S Wilkinson; G Strohmeyer; G Kreuzpainter
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

5.  On the etiology of Crohn disease.

Authors:  D Mishina; P Katsel; S T Brown; E C Gilberts; R J Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.